This award will fund UK early to mid-career researchers to spend between 6 and 12 months at the National Cancer Institute (NCI) Intramural Institutes in Bethesda USA:
- Centre for Cancer Research
- Division of Cancer Epidemiology and Genetics
The award is for UK-based early/mid-career researchers who are looking to gain training, develop skills and experience, and establish international collaborations with NCI researchers. It will support a transition to independence in cancer research.
Successful applicants will become NIHR Academy Members.
Applicants must have the support of an NCI host institution before submitting an application. This support can be facilitated as long as the applicant expresses interest by 7 June. See the guidance notes for more information on identifying and contacting NCI hosts.
Eligibility criteria
- Applicants must hold a relevant PhD or MD at the time of awarding.
- Individuals must not already hold a Chair at the point of awarding.
- Applicants must have the potential, and be on a trajectory, to become future leaders in cancer research within MRC-UKRI remit and/ or NIHR’s remit.
- The proposed Host Organisation must be a UK HEI, NHS body, or other provider of health and/or care services located in the UK or other organisation eligible for UKRI funding
- The proposed US placement (the NCI Host) must be at one of the two intramural centres directly funded by the NCI, Centre for Cancer Research or Division of Cancer Epidemiology and Genetics, in Bethesda USA
Funding
The award provides funding for:
- The salary of the award holder for 6-12 months
- Travel, accommodation and subsistence costs associated with visits to the NCI hosts
- Personal and family relocation costs
- Visa costs and health insurance
- Training and development costs up to £5,000
- Conference costs up to £2,000
- Some research costs and consumables
- NCI partner research groups will support standard consumables, but where substantial or exceptional additional research costs are required for the proposed research and skills development, costs may be requested where justified.
- Funding for clinical trials can not be requested, however, costs for collecting pilot data and conducting preliminary work to support future research funding applications can be included.
Full Economic Costings (FEC) are not covered by this award. Direct costs will be supported at 100%.
The Cancer Research Transatlantic DSE Award is funded through a partnership between the NIHR and the MRC. In-kind support is provided from the National Institutes of Health (NIH) NCI in the USA. All applications will be managed by the NIHR.